Page 37 - Central Drug Authority Annual Report 2021
P. 37

2.7 THE COLOMBO PLAN
             7KH &RORPER 3ODQ LV RQH RI WKH ROGHVW LQWHUJRYHUQPHQWDO
                                                               Programme for the Private Sector:  7KLV  SURJUDPPH  LV
             LQLWLDWLYHV  LQ  WKH  $VLDQ  3DFLˉF  5HJLRQ  DQG  ZDV  RIˉFLDOO\
                                                               JHDUHG WRZDUGV SURYLGLQJ WKRVH GHSHQGHQW RQ GUXJV ZLWK D
             ODXQFKHG E\ $XVWUDOLD  &DQDGD  ,QGLD  3DNLVWDQ  1HZ =HDODQG
                                                               ȟVHFRQG FKDQFHȠ WR OLYLQJ D OLIH RI TXDOLW\  7KH SURJUDPPH LV
             6UL /DQND DQG WKH 8QLWHG .LQJGRP LQ
                                                               WKHUHIRUH  FDOOHG WKH 6HFRQG &KDQFH 3URJUDPPH

             1) Aims and Objectives of The Colombo Plan
                                                               Programme for the Public Administration and Environment:
               ȧ 7R SURPRWH LQWHUHVW LQ VXSSRUW RI HFRQRPLF DQG VRFLDO
                                                               7KH DFWLYLWLHV RI WKLV SURJUDPPH IRFXV RQ FOLPDWH FKDQJH
                                                               DQG WKH HPSRZHUPHQW RI ZRPHQ  /RQJ WHUP 6FKRODUVKLSV
                 GHYHORSPHQW LQ PHPEHU VWDWHV
                                                               3URJUDPPH  7KLV SURJUDPPH SURYLGHV VFKRODUVKLSV WR WKRVH
               ȧ 7R SURPRWH WHFKQLFDO FR RSHUDWLRQ DQG WKH VKDULQJ RI
                                                               LQ QHHG
                 technology among member states, and
               •  7R  UHYLHZ  WKH  UHOHYDQW  LQIRUPDWLRQ   ,W  DOVR  DLPV  WR
                                                               2.8 ISSUP GLOBAL
                 IDFLOLWDWH  WKH  WUDQVIHU  DQG  VKDULQJ  RI  GHYHORSPHQW
                 experiences among member countries,  especially
                 WKRVH LQ WKH VRXWKHUQ KHPLVSKHUH
                                                               ,6683 *OREDO ZDV LQLWLDWHG LQ      WKURXJK ,1/  ZRUNLQJ LQ
                                                               FRQVXOWDWLRQ  ZLWK  WKH $IULFDQ  8QLRQ   2$6 &,&$'   &RORPER
             2) Programmes of Colombo Plan
                                                               3ODQ   812'&  DQG  :+2   ,W  ZDV  HVWDEOLVKHG  LQ  WKH  8QLWHG
                                                               .LQJGRP DV D QRW IRU SURˉW FRPSDQ\ OLPLWHG E\ JXDUDQWHH LQ
             7KH IRXU SHUPDQHQW SURJUDPPHV FDUULHG RXW E\ WKH &RORP-
                                                               )HEUXDU\       ,W LV D XQLTXH LQLWLDWLYH RIIHULQJ DQ LQWHUQD-
             ER 3ODQ DUH
                                                               tional and credible professional membership that brings
                                                               WRJHWKHU  ERWK  WKH  WUHDWPHQW  DQG  SUHYHQWLRQ  ZRUNIRUFH
                  7KH 'UXJ $GYLVRU\ 3URJUDPPH  '$3
                                                               concerned with substance abuse,
                  7KH 3URJUDPPH IRU 3XEOLF $GPLQLVWUDWLRQ DQG
                 (QYLURQPHQW  DQG 7KH 3URJUDPPH IRU
                                                               7KH ,6683 DLPV WR SURYLGH SURIHVVLRQDOV ZRUNLQJ LQ SXEOLF
                  3ULYDWH 6HFWRU 'HYHORSPHQW DQG WKH /RQJ WHUP
                                                               WUHDWPHQW  FHQWUHV  DQG  SUHYHQWLRQ  ˉHOGV   ZLWK  WUDLQLQJ  WR
                 6FKRODUVKLSV 3URJUDPPH
                                                               HTXLS WKHP ZLWK VNLOOV DQG NQRZOHGJH WR FRPEDW 6XEVWDQFH
                                                               8VH  'LVRUGHUV     ,W  HQDEOHV  WKHVH  SURIHVVLRQDOV  WR  DSSO\
             3) The Link between the CDA and the Colombo Plan
                                                               VFLHQFH  PDNLQJ LW DFFHVVLEOH DQG FRPSUHKHQVLEOH IRU HYHU\-
             7KH  &'$  KDV  VXSSRUWHG  WKH  &RORPER  3ODQ  LQLWLDWLYHV
                                                               RQH ZLWKLQ WKH LQWHUQDWLRQDO GUXJ WUHDWPHQW DQG SUHYHQWLRQ
             SURJUDPPHV DQG WUDLQLQJ VHVVLRQV ZLWKLQ 6RXWK $IULFD  2QFH
                                                               FRPPXQLW\  ,W LV DOVR SURIHVVLRQDOLVLQJ WKH SUHYHQWLRQ DQG
             DFFUHGLWHG  E\  WKH  6RXWK  $IULFDQ  4XDOLˉFDWLRQV  $XWKRULW\
                                                               treatment workforce, to promote quality standards, ethical,
              6$4$   WKH YDULRXV SURJUDPPHV VKRXOG EH YDOXDEOH WRROV LQ
                                                               DQG HYLGHQFH EDVHG SUDFWLFH  ,W LV DQ LQWHUQDWLRQDO RUJDQLVD-
             WKH &'$ȠV HIIRUWV WR VWUHQJWKHQ LWV VXSSRUW VWUXFWXUHV  36$)V
                                                               tion that was set up to meet the needs and challenges faced
             DQG /'$&V
                                                               E\ WKH SUHYHQWLRQ DQG WUHDWPHQW ZRUNIRUFH

             The key characteristics of these programmes are as follows:
                                                               )LQDOO\   SUHYHQWLRQ  DQG  WUHDWPHQW  VFLHQFH  KDV  PRYHG
             Drug Advisory Programme (DAP): 7KLV SURJUDPPH DLPV WR
                                                               VXEVWDQWLDOO\ RYHU UHFHQW \HDUV  7KH IROORZLQJ DUH WKH UHFHQW
             build capacity for drug demand reduction in the Asian and
                                                               FRXUVHV  WKDW  DUH  DLPHG  DW  SURYLGLQJ  SURIHVVLRQDOV  ZLWK
             3DFLˉF  5HJLRQ   ,W  HQFRXUDJHV  QDWLRQDO  HIIRUWV  DPRQJ
                                                               continuing education and sharpening their skills and knowl-
             PHPEHU  FRXQWULHV  WRZDUGV  GHPDQG  UHGXFWLRQ   '$3  LQLWLD-
                                                               HGJH LQ WKH ˉHOG
             WLYHV  LQFOXGH  WKH  HVWDEOLVKPHQW  RI  QDWLRQDO  GUXJ  IRFDO
                                                                 8QLYHUVDO 3UHYHQWLRQ &XUULFXOXP
             points, the formulation of national drug policy, the imple-
                                                                 8QLYHUVDO 7UHDWPHQW &XUULFXOXP
             PHQWDWLRQ RI GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYHV  WKH LQLWLD-
                                                               ,W LV LPSRUWDQW WR VWDWH WKDW WKH FRXUVHV DERYH  ZHUH VXSSRUW-
             WLRQ RI WKH $IJKDQ GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYH DQG WKH
                                                               HG E\ ,1/ DQG WKH &RORPER 3ODQ
             $VLDQ  &HQWUH  IRU  &HUWLˉFDWLRQ  DQG  (GXFDWLRQ  RI $GGLFWLRQ
             3URIHVVLRQDOV  $&&(
                                                               7KH (XURSHDQ 'UXJ 3UHYHQWLRQ 4XDOLW\ 6WDQGDUGV LV IXQGHG
                                                               E\  WKH  (XURSHDQ  8QLRQ  DQG  XQGHUWDNHQ  E\  WKH  (XURSHDQ
             The ACCE  initiatives  ZHUH  HVWDEOLVKHG  LQ        DV  WKH
                                                               3UHYHQWLRQ  6WDQGDUGV  3DUWQHUVKLS  DQG  WKH  ,QWHUQDWLRQDO
             WUDLQLQJ DQG FUHGHQWLDOLQJ DUP RI WKH '$3  7KH $&&( LV DQ
                                                               6WDQGDUGV RQ 'UXJ 8VH 3UHYHQWLRQ SURGXFHG E\ 812'&
             LQWHJUDO SDUW RI WKH JOREDO LQLWLDWLYH  IXQGHG E\ WKH %XUHDX
             IRU ,QWHUQDWLRQDO 1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV RI
             WKH 86 'HSDUWPHQW RI 6WDWH
             CHAPTER 4 - NDMP 2019 - 2024 IMPLEMENTATION ANALYSIS
 ,6683 LPSOHPHQWV LWV DFWLYLWLHV LQ FRQVXOWDWLRQ ZLWK    2.9 INTERNATIONAL NETWORK  ON HEPATITIS IN
      &DQDGLDQ &HQWUH RQ 6XEVWDQFH $EXVH  &&6$    SUBSTANCE USERS (INHSU)   7KLV  FKDSWHU  ZLOO  PHDVXUH  WKH  SHUIRUPDQFH  RI  QDWLRQDO         6WLPXODWH  UREXVW  DQG  VXVWDLQDEOH  HFRQRPLF  JURZWK
     &RORPER 3ODQ   GHSDUWPHQWV  DQG  3URYLQFLDO  6XEVWDQFH $EXVH  )RUXPV   WKH   DLPHG  DW  UHGXFLQJ  SRYHUW\   XQHPSOR\PHQW   DQG
     &RRSHUDWLRQ 3URJUDPPH RQ 'UXJV 3ROLFLHV  &232/$'    ,1+68  LV  DQ  LQWHUQDWLRQDO  RUJDQLVDWLRQ  GHGLFDWHG  WR   ODWWHU  LQFRUSRUDWLQJ  DOO  LQSXWV  IURP  /RFDO  'UXJ  $FWLRQ   LQHTXDOLWLHV
     (XURSHDQ 0RQLWRULQJ &HQWUH IRU 'UXJV DQG 'UXJ   VFLHQWLˉF NQRZOHGJH H[FKDQJH  NQRZOHGJH WUDQVODWLRQ DQG   &RPPLWWHHV  QRQ JRYHUQPHQWDO RUJDQLVDWLRQV RSHUDWLRQDO LQ
      $GGLFWLRQ  (0&''$    DGYRFDF\  IRFXVHG  RQ  KHSDWLWLV  &  SUHYHQWLRQ  DQG  FDUH  IRU   WKH SURYLQFH  DJDLQVW WKH JRDOV DQG REMHFWLYHV RI WKH 1'03     National Conference on Substance Abuse and Family Related
             ,W PXVW EH QRWHG KRZHYHU  WKDW QRW DOO GHSDUWPHQWV VXEPLW-
     (XURSHDQ 6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK  (8635    SHRSOH ZKR XVH GUXJV  ,QFUHDVLQJ KHSDWLWLV & WHVWLQJ  OLQNDJH   WHG UHSRUWV   6RPH RWKHU GHSDUWPHQWV GR QRW KDYH UHSUHVHQ-  Interventions Conference Resolutions
     2UJDQLVDWLRQ RI $PHULFDQ 6WDWHV ,QWHU $PHULFDQ 'UXJ        to care, treatment and cure among people who use drugs is   WDWLRQ  LQ  WKH  &'$  \HW   DV  QR  QRPLQDWLRQV  KDYH  \HW  EHHQ
      Abuse Control Commission (   RI SDUDPRXQW LPSRUWDQFH  7KLV LV DQ LQLWLDWLYH WKDW WKH &'$   UHFHLYHG IURP WKH DIIHFWHG GHSDUWPHQWV        'HYHORS DQG LPSOHPHQW WKH OHJDO IUDPHZRUN WR
 VXSSRUWV
      6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK  635                         UHVWULFW DFFHVV  WR DQG DYDLODELOLW\ RI DOFRKRO
      7KH (XURSHDQ 3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS   7KH H[WHQW WR ZKLFK WKH &'$ ZDV DEOH WR H[SORUH DQG H[SORLW   7KH DQDO\VLV RI UHSRUWV 1DWLRQDO 'HSDUWPHQWV DQG 3URYLQFLDO       6WUHQJWKHQ  PHFKDQLVPV  WR  PLQLPL]H  WKH  LOOHJDO
                                                                   PDQXIDFWXULQJ  VXSSO\ DQG DOO IRUPV RI WUDIˉFNLQJ RI
      8QLWHG 1DWLRQV 2IˉFH RQ 'UXJV DQG &ULPH  812'&    WKHVH SDUWQHUVKLSV DQG UHODWLRQVKLSV KDV QRW EHHQ RSWLPDO    6XEVWDQFH  $EXVH  )RUXPV  RQ  WKH  LPSOHPHQWDWLRQ  RI  WKH   licit and illicit drugs;
     8 6  'HSDUWPHQW RI 6WDWHȠV %XUHDX RI ,QWHUQDWLRQDO   ,QGLYLGXDO  GHSDUWPHQWV  ZHUH  KRZHYHU   DEOH  WR  IRUJH   1DWLRQDO  'UXJ  0DVWHU  3ODQ               IRU  WKH  UHSRUWLQJ       6WUHQJWKHQ  WKH  FROODERUDWLRQ  DQG  FRRUGLQDWLRQ
     1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV  ,1/    relationships and interact with these agencies in line with   SHULRG    $SULO        WR      0DUFK           LV  EDVHG  RQ  WKH   PHFKDQLVPV  WR  ˉJKW  WKH  VFRXUJH  RI  VXEVWDQFH
     :RUOG +HDOWK 2UJDQLVDWLRQ  :+2    VHFWRU SROLFLHV DQG VHUYLFH GHOLYHU\ PDQGDWHV DV LQGLFDWHG LQ   2XWFRPHV  RI  WKH    0HGLXP  7HUP  6WUDWHJLF  )UDPHZRUN    use/abuse;
 WKH GHSDUWPHQWDO DQG VHFWRU UHSRUWV EHORZ    076)              RI WKH 1DWLRQDO 'HYHORSPHQW 3ODQ   WKH       ,PSOHPHQW DQ LQWHJUDWHG DQG EDODQFHG DSSURDFK WKDW
             *RDOV RI WKH 1'03           DQG  WKH 5HVROXWLRQV RI WKH   includes demand  and supply reduction  strategies
             1DWLRQDO &RQIHUHQFH RQ 6XEVWDQFH $EXVH DQG )DPLO\ 5HODW-  required, including international cooperation;
             HG ,QWHUYHQWLRQV KHOG LQ (NXUKXOHQL RQ WKH   VW 2FWREHU ȝ       ,QFUHDVH  LQYHVWPHQW  LQ  KHDOWK   SUHYHQWLRQ   HDUO\
              QG 1RYHPEHU
                                                                   LQWHUYHQWLRQ   WUHDWPHQW   DQG  UHKDELOLWDWLRQ  DQG  DIWHU
                                                                   FDUH VHUYLFHV
             NDP MTSF Outcomes
                                                                     0DLQVWUHDP PRUDO UHJHQHUDWLRQ DQG UHVWRUDWLRQ LQ DOO
                                                                   VXEVWDQFH DEXVH SURJUDPPHV DQG VHUYLFHV
             $FFRUGLQJ WR WKH 076)  WKH FRPELQDWLRQ RI REMHFWLYHV ZLOO  LQ       ,PSURYH GDWD FROOHFWLRQ DQG XVH  VXUYHLOODQFH V\VWHP
             WKH  PHGLXP  WHUP  FRQWULEXWH  WR  LPSURYHG  KHDOWK   KXPDQ   IRU HYLGHQFH EDVHG SODQQLQJ DQG SURJUDPPLQJ
             ULJKWV  GHYHORSPHQW  DQG VHFXULW\ RXWFRPHV RI SHRSOH ZKR         0RELOL]H  DQG  LQYROYH  FRPPXQLWLHV   LQFOXGLQJ  )%2V
             XVH GUXJV LQ FRPPXQLWLHV  7KH 1'03             ZLOO EH   1*2V   &%2V   DFDGHPLFV   ODERXU   EXVLQHVV   UHVHDUFK
             H[SOLFLWO\ HYDOXDWHG RQ WKH H[WHQW WR ZKLFK WKH SODQ FRQWULE-  LQVWLWXWLRQV  HWF    WR  VWUHQJWKHQ  IDPLOLHV  LQ  WKH  ˉJKW
             XWHV WR  RU DFKLHYHV WKHVH RXWFRPHV                   against the scourge;
                ȧ  2XWFRPH    5HGXFHG OHYHOV RI SRYHUW\              6WUHQJWKHQ  UHJLRQDO   FRQWLQHQWDO   DQG  LQWHUQDWLRQDO
                ȧ  2XWFRPH    5HGXFHG OHYHOV RI LQHTXDOLW\         cooperation; and
                ȧ  2XWFRPH    5HGXFHG VRFLDO LOOV  LPSURYHG ZHOO EHLQJ          ,QFUHDVH WKH WD[ RI DOFRKRO EHYHUDJHV WR ˉJKW DOFRKRO
                    RI FKLOGUHQ  IDPLOLHV  DQG FRPPXQLWLHV         related harm;
                ȧ  2XWFRPH    (PSRZHUHG  UHVLOLHQW LQGLYLGXDOV  IDPLOLHV          (QVXUH  HTXDO  DFFHVV  DQG  GLVWULEXWLRQ  RI  UHVRXUFHV
                    DQG VXVWDLQDEOH FRPPXQLWLHV                    HVSHFLDOO\  IRU  FLYLO  VRFLHW\  DQG  RUJDQLVDWLRQV  IURP
                ȧ  2XWFRPH    ,PSURYHG VHFWRU FDSDELOLW\           informal settlement, urban and rural areas; and
                                                                     $FFHOHUDWH  LQ WKH VSLULW RI .KDXOH]D  WKH
             NDMP 2019- 2024 Goals                                 LPSOHPHQWDWLRQ RI WKHVH FRPPLWPHQWV WR JLYH HIIHFW
                                                                   WR WKH 1DWLRQDO 'UXJ 0DVWHU 3ODQ DW DOO VSKHUHV RI
                   'HPDQG UHGXFWLRQ DQG UHODWHG PHDVXUHV  LQFOXGLQJ WKH    JRYHUQPHQW
                    SUHYHQWLRQ DV ZHOO DV RWKHU KHDOWK UHODWHG LVVXHV
                   6XSSO\ UHGXFWLRQ DQG UHODWHG PHDVXUHV  HIIHFWLYH ODZ   7KH DERYH ZLOO EH XVHG DV PHDVXUHV DJDLQVW ZKLFK UHSRUWV
                  enforcement; responses to drug related crime; and   E\  WKH  QDWLRQDO  GHSDUWPHQWV  DQG  3URYLQFLDO  6XEVWDQFH
                  countering money laundering and promoting judicial   )RUXPV ZLOO EH DQDO\VHG   7KHVH PHDVXUHV ZLOO EH UHˊHFWHG
                  cooperation;                                 LQ WKH UHOHYDQW FROXPQV LQ WKH WDEOHV EHORZ
                   (QVXULQJ WKH DYDLODELOLW\ RI DQG DFFHVV WR FRQWUROOHG
                  VXEVWDQFHV  H[FOXVLYHO\  IRU  PHGLFDO  DQG  VFLHQWLˉF
                  SXUSRVHV  ZKLOH SUHYHQWLQJ WKHLU GLYHUVLRQ
                    ,GHQWLˉFDWLRQ DQG FRQWURO RI QHZ SV\FKRWURSLF SV\-
                  FKRDFWLYH VXEVWDQFHV
                    3URPRWH JRYHUQDQFH  OHDGHUVKLS  DQG DFFRXQWDELOLW\
                  IRU D FRRUGLQDWHG PXOWL VHFWRUDO HIIHFWLYH UHVSRQVH
                   6WUHQJWKHQ GDWD FROOHFWLRQ  PRQLWRULQJ  HYDOXDWLRQ  DQG
                  UHVHDUFK HYLGHQFH WR DFKLHYH WKH JRDOV  DQG
                                       Annual Report 2020/2021 Central Drug Authority                           35
   32   33   34   35   36   37   38   39   40   41   42